Works by Lagerstrom-Fermer, Maria

Results: 12

Genetic variation in DLG5 is associated with inflammatory bowel disease.

Published in:

Nature Genetics, 2004, v. 36, n. 5, p. 476, doi. 10.1038/ng1345

By:

Stoll, Monika;
Corneliussen, Brit;
Costello, Christine M;
Waetzig, Georg H;
Mellgard, Bjorn;
Koch, W Andreas;
Rosenstiel, Philip;
Albrecht, Mario;
Croucher, Peter J P;
Seegert, Dirk;
Nikolaus, Susanna;
Hampe, Jochen;
Lengauer, Thomas;
Pierrou, Stefan;
Foelsch, Ulrich R;
Mathew, Christopher G;
Lagerstrom-Fermer, Maria;
Schreiber, Stefan

Publication type:

Article

Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes.

Published in:

Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-08852-4

By:

Gan, Li-Ming;
Lagerström-Fermér, Maria;
Carlsson, Leif G.;
Arfvidsson, Cecilia;
Egnell, Ann-Charlotte;
Rudvik, Anna;
Kjaer, Magnus;
Collén, Anna;
Thompson, James D.;
Joyal, John;
Chialda, Ligia;
Koernicke, Thomas;
Fuhr, Rainard;
Chien, Kenneth R.;
Fritsche-Danielson, Regina

Publication type:

Article

Early Clinical Experience With AZD4831, A Novel Myeloperoxidase Inhibitor, Developed for Patients With Heart Failure With Preserved Ejection Fraction.

Published in:

CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 812, doi. 10.1111/cts.12859

By:

Nelander, Karin;
Lagerstrom‐Fermer, Maria;
Amilon, Carl;
Michaëlsson, Erik;
Heijer, Maria;
Kjaer, Magnus;
Russell, Muir;
Han, David;
Lindstedt, Eva‐Lotte;
Whatling, Carl;
Gan, Li‐Ming;
Ericsson, Hans

Publication type:

Article

Initial Clinical Experience with AZD5718, a Novel Once Daily Oral 5‐Lipoxygenase Activating Protein Inhibitor.

Published in:

CTS: Clinical & Translational Science, 2018, v. 11, n. 3, p. 330, doi. 10.1111/cts.12546

By:

Ericsson, Hans;
Nelander, Karin;
Lagerstrom‐fermer, Maria;
Balendran, Clare;
Bhat, Maria;
Chialda, Ligia;
Gan, Li‐ming;
Heijer, Maria;
Kjaer, Magnus;
Lambert, John;
Lindstedt, Eva‐lotte;
Forsberg, Gun‐britt;
Whatling, Carl;
Skrtic, Stanko

Publication type:

Article

Level of heteroplasmy for the mitochondrial mutation A3243G correlates with age at onset of diabetes and deafness.

Published in:

Human Mutation, 1998, v. 12, n. 1, p. 52, doi. 10.1002/(SICI)1098-1004(1998)12:1<52::AID-HUMU8>3.0.CO;2-K

By:

Olsson, Charlotta;
Zethelius, Björn;
Lagerström-Fermér, Maria;
Asplund, Johan;
Berne, Christian;
Landegren, Ulf

Publication type:

Article

Sex differences in proteomic correlates of coronary microvascular dysfunction among patients with heart failure and preserved ejection fraction.

Published in:

European Journal of Heart Failure, 2022, v. 24, n. 4, p. 681, doi. 10.1002/ejhf.2435

By:

Chandramouli, Chanchal;
Ting, Tay W.;
Tromp, Jasper;
Agarwal, Anubha;
Svedlund, Sara;
Saraste, Antti;
Hage, Camilla;
Tan, Ru‐San;
Beussink‐Nelson, Lauren;
Lagerström Fermer, Maria;
Gan, Li‐Ming;
Lund, Lars;
Shah, Sanjiv J.;
Lam, Carolyn S.P.

Publication type:

Article

Safety, tolerability, pharmacokinetics and effect on serum uric acid of the myeloperoxidase inhibitor AZD4831 in a randomized, placebo‐controlled, phase I study in healthy volunteers.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 4, p. 762, doi. 10.1111/bcp.13855

By:

Gan, Li‐Ming;
Lagerström‐Fermér, Maria;
Ericsson, Hans;
Nelander, Karin;
Lindstedt, Eva‐Lotte;
Michaëlsson, Erik;
Kjaer, Magnus;
Heijer, Maria;
Whatling, Carl;
Fuhr, Rainard

Publication type:

Article

Phase 1 Pharmacokinetic Study of AZD5718 in Healthy Volunteers: Effects of Coadministration With Rosuvastatin, Formulation and Food on Oral Bioavailability.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 3, p. 411, doi. 10.1002/cpdd.756

By:

Ericsson, Hans;
Nelander, Karin;
Heijer, Maria;
Kjaer, Magnus;
Lindstedt, Eva‐Lotte;
Albayaty, Muna;
Forte, Pablo;
Lagerström‐Fermér, Maria;
Skrtic, Stanko

Publication type:

Article

The level of the mitochondrial mutation A3243G decreases upon ageing in epithelial cells from individuals with diabetes and deafness.

Published in:

European Journal of Human Genetics, 2001, v. 9, n. 12, p. 917, doi. 10.1038/sj.ejhg.5200742

By:

Olsson, Charlotta;
Johnsen, Elsy;
Nilsson, Mats;
Wilander, Erik;
Syvänen, Ann-Christine;
Lagerström-Fermér, Maria

Publication type:

Article

PROspective evaluation of coronary FLOW reserve and molecular biomarkers in patients with established coronary artery disease the PROFLOW-trial: cross-sectional evaluation of coronary flow reserve.

Published in:

2019

By:

Haraldsson, Inger;
Gan, Li-Ming;
Svedlund, Sara;
Torngren, Kristina;
Westergren, Helena U;
Redfors, Björn;
Lagerström-Fermér, Maria;
Angerås, Oskar;
Råmunddal, Truls;
Petursson, Petur;
Odenstedt, Jacob;
Albertsson, Per;
Erlinge, David;
Omerovic, Elmir

Publication type:

journal article

Regional differences and coronary microvascular dysfunction in heart failure with preserved ejection fraction.

Published in:

ESC Heart Failure, 2023, v. 10, n. 6, p. 3729, doi. 10.1002/ehf2.14569

By:

Erhardsson, Mikael;
Ljung Faxén, Ulrika;
Venkateshvaran, Ashwin;
Svedlund, Sara;
Saraste, Antti;
Lagerström Fermer, Maria;
Gan, Li‐Ming;
Shah, Sanjiv J.;
Tromp, Jasper;
SP Lam, Carolyn;
Lund, Lars H.;
Hage, Camilla

Publication type:

Article

Understanding Enamel Formation from Mutations Causing X-Linked Amelogenesis Imperfecta.

Published in:

Connective Tissue Research, 1995, v. 32, n. 1-4, p. 241, doi. 10.3109/03008209509013729

By:

Lagerström-fermér, Maria;
Landegren, Ulf

Publication type:

Article